背景

Discoloured leg syndrome (DLS) is a rare phenomenon that 能 发生 after receipt of an injected vaccine. It is a transient condition involv

 either an even or patchy colour change to the skin in the lower extremities (red, blue or purple) 
 
may or may not involve petechiae (
pin-point red spots on the skin或者 swelling.

诊断

DLS 是 be diagnosed based on clinical presentation (e.g. symptom profile, onset of symptoms and symptom resolution).

Unlike injection site reactions (ISRs), DLS does not radiate from the site of injection, and can impact  or both leg, even if only one injection has been administered. Discolouration can also extend up to the pelvis.

Investigations are generally not required. Despite the presence of petechiae, there is no drop in platelet count.

As DLS involves skin changes and symptoms can occur quickly, it is important to differentiate it from anaphylaxis, especially if symptoms start within 30 minutes of vaccination.

Association and incidence

DLS is reported at a rate of 58 per 100,000 children vaccinated. Although the median onset time for colour change is approximately 3.5 hours, DLS can be seen quite quickly post-vaccination (within 30 minutes). Where symptoms of petechiae occur, the median onset time is 12 hours following vaccination. Generally, colour change (median duration = approximately 2 hours) does not last as long as petechiae (median duration = 54 hours).

治疗

As a precaution, assessment of airway, breathing and circulation is advised.

Symptoms of DLS are transient and will resolve on their own without treatment.

Any adverse event following immunisation (AEFI), including DLS, should be reported to the adverse event reporting service in your jurisdiction. In Victoria, this is 赛维克.

对未来剂量的影响

Recurrence of DLS 是 uncommon, but can occur. However, DLS 是 not a contraindication to receiving future vaccines. Given that DLS appears to be age-related, families can be reassured that children are less likely to experience symptoms as they get older.

作者: Rachael McGuire (MVEC Education Nurse Coordinator), Dr Shidan Tosif (Senior Research Fellow, SAEFVIC) and Prof Nigel Crawford (Director, MVEC).

日期: April 2026

本章节内的材料将随着新信息和新疫苗的出现而进行更新。墨尔本疫苗教育中心(MVEC)职员定期审阅材料的准确性。

您不应将本网站中的信息视为针对您个人健康或您家人健康的具体专业医疗建议。如有医疗问题,包括关于疫苗接种、药物和其他治疗的决策,您应始终咨询医疗专业人士。

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个